Other
Gender
Gender is an intervention with 4 clinical trials. Currently 1 active trials ongoing. Historical success rate of 100.0%.
Total Trials
4
Max Phase
—
Type
OTHER
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 3 completed trials
Completion Rate
100%(3/3)
Active Trials
1(25%)
Results Posted
0%(0 trials)
Phase Distribution
No phase data available
Trial Status & Enrollment
Completion Rate
100.0%
3 of 3 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
1
trials recruiting
Total Trials
4
all time
Status Distribution
Active(1)
Completed(3)
Detailed Status
Completed3
Recruiting1
Development Timeline
Analytics
Development Status
Total Trials
4
Active
1
Success Rate
100.0%
Trials by Status
completed375%
recruiting125%
Recent Activity
1 active trials
Showing 4 of 4
recruiting
Purinergic Signaling and the Postmenopausal Heart
NCT06015776
completed
COVID-19 Vaccination Uptake in Belgium : Sociodemographic and Socioeconomic Disparities
NCT05373420
completed
Gender Differences in Social Cognition in Patients With Schizophrenia of Recent Diagnosis and Healthy Controls Subjects
NCT02575209
completed
Obesity-related Genes in Taiwanese Undergoing Weight Loss
NCT01684280
Clinical Trials (4)
Showing 4 of 4 trials
NCT06015776
Purinergic Signaling and the Postmenopausal Heart
NCT05373420
COVID-19 Vaccination Uptake in Belgium : Sociodemographic and Socioeconomic Disparities
NCT02575209
Gender Differences in Social Cognition in Patients With Schizophrenia of Recent Diagnosis and Healthy Controls Subjects
NCT01684280
Obesity-related Genes in Taiwanese Undergoing Weight Loss
All 4 trials loaded
Drug Details
- Intervention Type
- OTHER
- Total Trials
- 4